Anticoagulation therapy for atrial fibrillation and coronary disease.
Ezekowitz
M D
MD
Yale University School of Medicine, New Haven, Connecticut, USA.
D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D004452:Echocardiography; D006801:Humans; D020521:Stroke / Q000517:prevention & control; D013923:Thromboembolism / Q000517:prevention & control; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin; D001241:Aspirin